These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24565770)

  • 1. Change in asthma control over time: predictors and outcomes.
    Schatz M; Zeiger RS; Yang SJ; Chen W; Crawford W; Sajjan S; Allen-Ramey F
    J Allergy Clin Immunol Pract; 2014; 2(1):59-64. PubMed ID: 24565770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations.
    Bateman ED; Buhl R; O'Byrne PM; Humbert M; Reddel HK; Sears MR; Jenkins C; Harrison TW; Quirce S; Peterson S; Eriksson G
    J Allergy Clin Immunol; 2015 Jun; 135(6):1457-64.e4. PubMed ID: 25258144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs.
    Sawicki GS; Vilk Y; Schatz M; Kleinman K; Abrams A; Madden J
    J Asthma; 2010 Jun; 47(5):574-80. PubMed ID: 20560831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, Canada.
    Zhang T; Smith MA; Camp PG; Carleton BC
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):744-51. PubMed ID: 23559540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of severe asthma and low asthma control among Danish adults.
    von Bülow A; Kriegbaum M; Backer V; Porsbjerg C
    J Allergy Clin Immunol Pract; 2014; 2(6):759-67. PubMed ID: 25439368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of asthma control in tertiary level in Turkey: a cross-sectional multicenter survey.
    Turktas H; Mungan D; Uysal MA; Oguzulgen K;
    J Asthma; 2010 Jun; 47(5):557-62. PubMed ID: 20560829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
    Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
    CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations.
    Zeiger RS; Yegin A; Simons FE; Haselkorn T; Rasouliyan L; Szefler SJ; Chipps BE;
    Ann Allergy Asthma Immunol; 2012 Feb; 108(2):81-7. PubMed ID: 22289725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter observational study of US adults with acute asthma: who are the frequent users of the emergency department?
    Hasegawa K; Sullivan AF; Tovar Hirashima E; Gaeta TJ; Fee C; Turner SJ; Massaro S; Camargo CA;
    J Allergy Clin Immunol Pract; 2014; 2(6):733-40. PubMed ID: 25439365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma control in Canada: no improvement since we last looked in 1999.
    McIvor RA; Boulet LP; FitzGerald JM; Zimmerman S; Chapman KR
    Can Fam Physician; 2007 Apr; 53(4):672-7. PubMed ID: 17872718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with the control of severe asthma.
    Hermosa JL; Sánchez CB; Rubio MC; Mínguez MM; Walther JL
    J Asthma; 2010 Mar; 47(2):124-30. PubMed ID: 20170317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Gossage D; Tran TN
    J Allergy Clin Immunol Pract; 2014; 2(6):741-50. PubMed ID: 25439366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factors influencing asthma course and the degree of control in the patients assessed with own questionnaire and Asthma Control Test (ACT)].
    Krasnodębska P; Hermanowicz-Salamon J; Domagała-Kulawik J; Chazan R
    Pneumonol Alergol Pol; 2012; 80(3):198-208. PubMed ID: 22562271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncontrolled asthma among children: impairment in social functioning and sleep.
    Dean BB; Calimlim BC; Sacco P; Aguilar D; Maykut R; Tinkelman D
    J Asthma; 2010 Jun; 47(5):539-44. PubMed ID: 20536279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving asthma outcomes in large populations.
    Schatz M; Zeiger RS
    J Allergy Clin Immunol; 2011 Aug; 128(2):273-7. PubMed ID: 21497885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS; Yawn BP
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suboptimal asthma control: prevalence, detection and consequences in general practice.
    Chapman KR; Boulet LP; Rea RM; Franssen E
    Eur Respir J; 2008 Feb; 31(2):320-5. PubMed ID: 17959642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives.
    O'Connor RD; Gilmore AS; Manjunath R; Stanford RH; Legorreta AP; Jhingran PM
    Curr Med Res Opin; 2006 Mar; 22(3):453-61. PubMed ID: 16574029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of validated psychometric tools to subsequent medical utilization for asthma.
    Schatz M; Mosen D; Apter AJ; Zeiger RS; Vollmer WM; Stibolt TB; Leong A; Johnson MS; Mendoza G; Cook EF
    J Allergy Clin Immunol; 2005 Mar; 115(3):564-70. PubMed ID: 15753905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.